These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19344947)
1. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Agarwal A; Gupta U; Asthana A; Jain NK Biomaterials; 2009 Jul; 30(21):3588-96. PubMed ID: 19344947 [TBL] [Abstract][Full Text] [Related]
2. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate. Kurmi BD; Gajbhiye V; Kayat J; Jain NK J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447 [TBL] [Abstract][Full Text] [Related]
4. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859 [TBL] [Abstract][Full Text] [Related]
5. Dendronized nanoconjugates of lysine and folate for treatment of cancer. Jain K; Gupta U; Jain NK Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808 [TBL] [Abstract][Full Text] [Related]
6. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery. Cao W; Zhou J; Mann A; Wang Y; Zhu L Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062 [TBL] [Abstract][Full Text] [Related]
7. Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. Peng M; Li H; Luo Z; Kong J; Wan Y; Zheng L; Zhang Q; Niu H; Vermorken A; Van de Ven W; Chen C; Zhang X; Li F; Guo L; Cui Y Nanoscale; 2015 Jul; 7(25):11155-62. PubMed ID: 26062012 [TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
9. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers. Birdhariya B; Kesharwani P; Jain NK Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759 [TBL] [Abstract][Full Text] [Related]
10. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells. Pramod PS; Shah R; Jayakannan M Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322 [TBL] [Abstract][Full Text] [Related]
11. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
12. Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. Jain K; Jain NK J Nanosci Nanotechnol; 2014 Jul; 14(7):5075-87. PubMed ID: 24757983 [TBL] [Abstract][Full Text] [Related]
13. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics. Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175 [TBL] [Abstract][Full Text] [Related]
14. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters. Kumar P; Paknikar KM; Gajbhiye V Colloids Surf B Biointerfaces; 2018 Nov; 171():437-444. PubMed ID: 30075419 [TBL] [Abstract][Full Text] [Related]
15. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers. Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521 [TBL] [Abstract][Full Text] [Related]
16. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. Du YZ; Weng Q; Yuan H; Hu FQ ACS Nano; 2010 Nov; 4(11):6894-902. PubMed ID: 20939508 [TBL] [Abstract][Full Text] [Related]
18. Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam. Prajapati RN; Tekade RK; Gupta U; Gajbhiye V; Jain NK Mol Pharm; 2009; 6(3):940-50. PubMed ID: 19231841 [TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of PAMAM-DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release properties. Cheng L; Hu Q; Cheng L; Hu W; Xu M; Zhu Y; Zhang L; Chen D Colloids Surf B Biointerfaces; 2015 Dec; 136():37-45. PubMed ID: 26360738 [TBL] [Abstract][Full Text] [Related]
20. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent. Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]